AorTech International
plc, is an AIM (Alternate Investment Market), London listed company which
wholly owns AorTech Biomaterials based in Melbourne, Australia.
AorTech Biomaterials was formed in July 1997 to commercialize a range of medical grade polyurethanes for medical implants developed by the Commonwealth Scientific and Industrial Research Organization (CSIRO).
The company owns all of the intellectual
property to exploit Elast-Eon™ polyurethanes. It was fully acquired
by AorTech in March 2001.
AorTech's vision for growth
AorTech is firmly focused on the development and refinement of polymeric
material technologies for the medical community. Our aim is to provide
a wide range of high performance Elast-Eon™ materials, in a variety
of application specific formulations and densities, for use in medical
devices.
Revenue from the licensing
and supply of Elast-Eon™ materials is currently generated through:
- Up-front license fees
- Milestone payments
- Product royalties
- Material supplies
|
